Feasibility of Valve-in-Valve Procedure for Degenerated St. Jude Medical Trifecta (TM) Bioprosthesis - Archive ouverte HAL Access content directly
Journal Articles Journal of Heart Valve Disease Year : 2015

Feasibility of Valve-in-Valve Procedure for Degenerated St. Jude Medical Trifecta (TM) Bioprosthesis

Abstract

The valve-in-valve (ViV) procedure is an option for patients with symptomatic structural degeneration of a bioprosthesis and excessive reoperative risk. The risk of coronary obstruction appears to be increased if ViV is performed for certain pericardial prostheses in which the leaflets are mounted outside the stent posts. Herein is described a successful ViV for a degenerated Trifecta aortic bioprosthesis, and the technical considerations for performing a ViV procedure within such types of prosthesis are considered. Emphasis is placed on the importance of preoperative investigations (computed tomography scan-based measurements of coronary ostial height and of sinus of Valsalva diameters), and on the precise deployment of the valve (transapical approach with transesophageal echocardiography control) to minimize the risk of major complications. The presence of a failing Trifecta bioprosthesis should not be considered an absolute contraindication to ViV on the basis of the risk of coronary obstruction

Keywords

Not file

Dates and versions

hal-01279135 , version 1 (25-02-2016)

Identifiers

  • HAL Id : hal-01279135 , version 1
  • PUBMED : 26897821

Cite

Jean-Philippe Verhoye, Majid Harmouche, Reda Belhaj Soulami, Christophe Thebault, Dominique Boulmier, et al.. Feasibility of Valve-in-Valve Procedure for Degenerated St. Jude Medical Trifecta (TM) Bioprosthesis. Journal of Heart Valve Disease, 2015, 24 (4), pp.484--486. ⟨hal-01279135⟩
82 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More